Balixafortide (a CXCR4 antagonist) plus eribulin in HER2-negative metastatic breast cancer (MBC): A Phase I open-label trial. (April 2018)
- Record Type:
- Journal Article
- Title:
- Balixafortide (a CXCR4 antagonist) plus eribulin in HER2-negative metastatic breast cancer (MBC): A Phase I open-label trial. (April 2018)
- Main Title:
- Balixafortide (a CXCR4 antagonist) plus eribulin in HER2-negative metastatic breast cancer (MBC): A Phase I open-label trial
- Authors:
- Kaufman, P.A.
Pernas, S.
Martin, M.
Gil-Martin, M.
Gomez Pardo, P.
Sara, L.T.
Manso, L.
Ciruelos, E.
Perez-Fidalgo, J.A.
Hernando, C.
Ademuyiwa, F.O.
Weilbaecher, K.
Mayer, I.
Pluard, T.J.
Martinez Garcia, M.
Vahdat, L.
Wach, A.
Barker, D.
Romagnoli, B.
Cortes, J. - Abstract:
- Is Part Of:
- European journal of cancer. Volume 92(2018)Supplement 3
- Journal:
- European journal of cancer
- Issue:
- Volume 92(2018)Supplement 3
- Issue Display:
- Volume 92, Issue 3 (2018)
- Year:
- 2018
- Volume:
- 92
- Issue:
- 3
- Issue Sort Value:
- 2018-0092-0003-0000
- Page Start:
- S117
- Page End:
- S118
- Publication Date:
- 2018-04
- Subjects:
- Cancer -- Periodicals
Neoplasms -- Periodicals
Cancer -- Périodiques
Cancer
Tumors
Electronic journals
Periodicals
Electronic journals
616.994 - Journal URLs:
- http://www.sciencedirect.com/science/journal/09598049 ↗
http://rzblx1.uni-regensburg.de/ezeit/warpto.phtml?colors=7&jour_id=2879 ↗
http://www.clinicalkey.com/dura/browse/journalIssue/09598049 ↗
http://www.clinicalkey.com.au/dura/browse/journalIssue/09598049 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/S0959-8049(18)30575-6 ↗
- Languages:
- English
- ISSNs:
- 0959-8049
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3829.725100
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 6436.xml